Trial intelligence / Profile preview

Adverse Effects of RBC Transfusions

NCT00838331Phase 2Completed

Sponsor
Emory University
Start
Apr 2009
Primary completion
May 2013
Modality
Recombinant Proteins and Enzymes, Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of red blood cells in anemia, sponsored by Emory University. Started Apr 2009; status: completed.

02

Drugs

red blood cells
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00838331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00838331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call